Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Exposure to Guideline-Recommended Quadruple Therapy after First Hospitalisation for HFrEF in France

In 2021, the European Society of Cardiology updated its guidelines for managing heart failure with reduced left ventricular ejection fraction (HFrEF), recommending a four-drug regimen combining an SGLT2 inhibitor, a beta-blocker, a mineralocorticoid receptor antagonist, and a renin-angiotensin-aldosterone system...

Gaël-Sean Marqueyssat, Audrey Dintilhac, O. Toulza et al. · 0 citations
Open access Sep 2026

Intensive titration for elderly patients with heart failure.

An intensive titration program for HFrEF therapy appears feasible and relatively safe in elderly patients and was associated with short-term clinical and biological benefits.

Lison Benezech, M. Cherbi, O. Toulza et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.